RNA Manufacturing Solutions
-
Regionalized Filter Supply Chain: Biopharma Supply, Reimagined
10/16/2025
Discover a regionalized filtration network that delivers consistency, security, and sustainability for biopharma manufacturing—featuring ISO-certified sites, climate-neutral operations, and a broad filter portfolio.
-
Control Software For Industrial Applications
5/1/2026
Learn how integrated process control, scalable workflows, and secure automation help teams plan, run, and analyze bioprocesses efficiently across research, development, and manufacturing.
-
Oligonucleotide Synthesis Solutions
12/9/2024
Discover innovative approaches to oligonucleotide synthesis, showcasing their superior performance compared to traditional liquid chromatography methods.
-
TakeoneĀ® Design Services For Aseptic Sampling Solutions
Have a particular need and can’t find a standard solution? Sartorius offers different design services to fine-tune your sampling plan to your exact requirements.
-
mRNA Raw Materials: A Clear Path To Market
4/9/2024
Design your mRNA manufacturing process with the certainty of fit-for-purpose standards for raw materials.
-
Bioreactors Designed For Cell Growth And Expansion
12/13/2024
Xcellerex™ X-platform bioreactors offer modular, scalable solutions for bioprocessing, enhancing productivity with user-friendly features, optimized design, adaptable automation, and efficient fluid management for seamless operation.
-
New Next-Generation GMP Facility
5/16/2023
A new state-of-the-art GMP facility has been created to accelerate the development of CRISPR-based cell and gene therapies, overcoming challenges such as procuring reliable GMP-grade sgRNA persist.
-
Vaccinia Capping System mRNA Guanylyltransferase And mRNA Methyltransferase
12/5/2025
mRNA Vaccinia Capping System: Proven. Scalable. Tailored to the needs of biopharma companies developing mRNA-based therapies.
-
Labscale Lipid Nanoparticle Production: IJM NanoScaler
12/9/2024
The benchtop IJM NanoScaler system is designed for lipid nanoparticle R&D – allowing scientists to screen for the optimal process parameters for the formulation of API-containing lipid nanoparticles.
-
LC/MS/MS Vs. LC/HRMS: Identifying And Quantifying Oligonucleotides
2/5/2025
As OGNT-based therapeutics continue to gain traction in drug development, precise identification and quantification are essential for ensuring their efficacy and safety.